Sign in Pull a receipt

HRTX

HERON THERAPEUTICS, INC. /DE/

Biotechnology · Biotechnology

$173.25 sample

+1.77 (+1.03%) 1D

Market cap

$315.3B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-13

Alerts

8

Price$173.25 -4.76% 3M daily closessample

188.60171.09

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21INSInsider buy: Chief Executive Officer
Oct 13SEC10-Q filed
Oct 05INSInsider buy: Director
Sep 25INSInsider sell: 10% owner
Sep 18INSInsider sell: General Counsel
Sep 11INSInsider buy: Director
Sep 08SECDEF 14A filed
Sep 03INSInsider buy: Chief Executive Officer

Sign up to see the real HRTX record →

Company facts

SEC EDGAR registration

Name: HERON THERAPEUTICS, INC. /DE/
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -38sample, -100 to +100
Reporting currency: USD

Who is positioning in HRTX

sample

Insiders: 6 insider transactions over 90 days, net selling, $765.3M
Congress: 2 members traded over 90 days
Institutions · 13F: 10 funds hold $5.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$11.7B +14.5% y/y

Q4 2024Q3 2026

Inventory$7.0B +8.3% y/y

Q4 2024Q3 2026

Accounts receivable$5.2B +14.3% y/y

Q4 2024Q3 2026

Total debt$13.8B +8.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $144.6B +3.0% 3M
Sample peer B: $220.3B -3.7% 3M
Sample peer C: $126.9B -4.3% 3M
Sample peer D: $190.4B -10.8% 3M
Sample peer E: $256.8B -2.2% 3M